Key result
Precision midlife CV risk targeting shows promise for preventing cardiovascular and neurodegenerative diseases.
Why the study?
Cognitive impairment and neurodegenerative diseases frequently co-occur with cardiovascular disease due to overlapping risk factors and pathologies, necessitating targeted prevention strategies.
Highlights the importance of managing midlife cardiovascular risk factors through a precision, age-specific approach to simultaneously prevent cardiovascular and neurodegenerative diseases.
Cognitive impairment and neurodegenerative diseases (NDDs) frequently co-occur with cardiovascular disease due to overlapping risk factors and pathologies. Midlife cardiovascular risks such as hypertension, diabetes, dyslipidemia, smoking, and obesity greatly contribute to dementia risk, and are prime targets for risk reduction strategies. Effective management of these factors requires a precision, age-specific approach, as interventions beneficial in midlife may need to be modified in late life. Integrating genomics, biomarkers, risk scores, and individualized profiling enables more accurate risk stratification and targeted prevention across the lifespan, offering a promising strategy to reduce the dual burden of cardiovascular and NDDs.
No takes yet. Share an insight, caveat, or question.
Murray et al. (2026) conducted a review in Cognitive impairment, neurodegenerative diseases, and cardiovascular disease. Cardiovascular risk reduction strategies was evaluated. Targeting midlife cardiovascular risk factors through precision, age-specific approaches integrating genomics and biomarkers offers a promising strategy to prevent neurodegenerative and cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: